Exosites, ligands and complex formation: novel determinants of protease specificity

外位点、配体和复合物形成:蛋白酶特异性的新决定因素

基本信息

  • 批准号:
    326803-2013
  • 负责人:
  • 金额:
    $ 2.19万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Discovery Grants Program - Individual
  • 财政年份:
    2016
  • 资助国家:
    加拿大
  • 起止时间:
    2016-01-01 至 2017-12-31
  • 项目状态:
    已结题

项目摘要

Proteins are one of the three building blocks of life and there are at least 100,000 different of them in our body. During their life-time, all of these proteins will encounter protein-degrading enzymes, called proteases, which will either lead to their activation, inactivation, modification or complete removal. Proteolysis, the degradation of proteins, is thus a fundamental process and must be tightly regulated. A random degradation of proteins would lead to severe cell and tissue damage. The selective protein degradation is accomplished by an army of about 700 different proteases. How do all these proteases recognize their protein substrates? Our research proposal aims to answer this question. As proteins can be very large, proteases do likely recognize certain surface features on their target substrates which can be remote from the actual cleavage site. We have identified so-called exosites on elastin-degrading proteases, which specifically interact with this protein. Without the binding of elastin to the exosites, no degradation occurs. We also hypothesize that these exosite protein interactions situate the substrate into the right orientation to allow cleavage or even modulate the structure of the substrate to make cleavage easier. Elastin is one of the most abundant but also most protease-resistant proteins in our bodies and is responsible for the integrity and elasticity of our organs including arteries, lung and skin. Interestingly, the same exosites are also used by another protease to form a protease complex which specifically degrades collagen, another major structural protein. This tells us that the same or similar exosites can be exploited for the degradation of different proteins using different mechanisms. Using biochemical, structural, and cellular approaches, we will characterize the nature and architectures of those exosites and explore novel mechanisms of selective protein degradation. We will also characterize certain ligands which interact with exosites and regulate the substrate specificity of these proteases.
蛋白质是生命的三大组成部分之一,我们体内至少有10万种不同的蛋白质。在它们的一生中,所有这些蛋白质都会遇到蛋白质降解酶,称为蛋白酶,这将导致它们的激活、失活、修饰或完全去除。因此,蛋白质分解,即蛋白质的降解,是一个基本的过程,必须严格控制。蛋白质的随机降解会导致严重的细胞和组织损伤。蛋白质的选择性降解是由大约700种不同的蛋白酶组成的大军完成的。所有这些酶是如何识别它们的蛋白质底物的?我们的研究提案旨在回答这个问题。由于蛋白质可能非常大,所以蛋白水解酶很可能识别其目标底物上的某些表面特征,这些表面特征可能远离实际的切割位点。我们已经确定了弹性蛋白降解酶上的所谓外切酶,它与这种蛋白特异地相互作用。如果没有弹性蛋白与胞外的结合,就不会发生降解。我们还假设,这些胞外蛋白相互作用使底物处于正确的方向,以允许切割,甚至调节底物的结构,使切割更容易。弹性蛋白是我们身体中含量最丰富但也是最耐蛋白酶的蛋白质之一,它负责我们包括动脉、肺和皮肤在内的器官的完整性和弹性。有趣的是,同样的外切酶也被另一种酶利用来形成一种蛋白酶复合体,它专门降解另一种主要结构蛋白-胶原蛋白。这告诉我们,相同或相似的外生体可以利用不同的机制来降解不同的蛋白质。使用生化、结构和细胞方法,我们将描述这些外显体的性质和结构,并探索选择性蛋白质降解的新机制。我们还将表征某些与外切酶相互作用的配体,并调节这些蛋白酶的底物专一性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bromme, Dieter其他文献

Affinity Crystallography: A New Approach to Extracting High-Affinity Enzyme Inhibitors from Natural Extracts
  • DOI:
    10.1021/acs.jnatprod.6b00215
  • 发表时间:
    2016-08-01
  • 期刊:
  • 影响因子:
    5.1
  • 作者:
    Aguda, Adeleke H.;Lavallee, Vincent;Bromme, Dieter
  • 通讯作者:
    Bromme, Dieter
Characterization of cathepsin S exosites that govern its elastolytic activity
  • DOI:
    10.1042/bcj20190847
  • 发表时间:
    2020-01-01
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Andrault, Pierre-Marie;Panwar, Preety;Bromme, Dieter
  • 通讯作者:
    Bromme, Dieter
Aging-associated modifications of collagen affect its degradation by matrix metalloproteinases
  • DOI:
    10.1016/j.matbio.2017.06.004
  • 发表时间:
    2018-01-01
  • 期刊:
  • 影响因子:
    6.9
  • 作者:
    Panwar, Preety;Butler, Georgina S.;Bromme, Dieter
  • 通讯作者:
    Bromme, Dieter
Tanshinones that selectively block the collagenase activity of cathepsin K provide a novel class of ectosteric antiresorptive agents for bone
  • DOI:
    10.1111/bph.14133
  • 发表时间:
    2018-03-01
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Panwar, Preety;Law, Simon;Bromme, Dieter
  • 通讯作者:
    Bromme, Dieter
Expression of elastolytic cathepsins in human skin and their involvement in age-dependent elastin degradation

Bromme, Dieter的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bromme, Dieter', 18)}}的其他基金

The ligase activity of proteases: Do proteases make proteins?
蛋白酶的连接酶活性:蛋白酶能产生蛋白质吗?
  • 批准号:
    RGPIN-2019-06720
  • 财政年份:
    2022
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual
The ligase activity of proteases: Do proteases make proteins?
蛋白酶的连接酶活性:蛋白酶能产生蛋白质吗?
  • 批准号:
    RGPIN-2019-06720
  • 财政年份:
    2021
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual
The ligase activity of proteases: Do proteases make proteins?
蛋白酶的连接酶活性:蛋白酶能产生蛋白质吗?
  • 批准号:
    RGPIN-2019-06720
  • 财政年份:
    2020
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual
Side effect-free cathepsin K targeting drugs for skeletal diseases
用于骨骼疾病的无副作用组织蛋白酶 K 靶向药物
  • 批准号:
    523434-2018
  • 财政年份:
    2019
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Collaborative Health Research Projects
The ligase activity of proteases: Do proteases make proteins?
蛋白酶的连接酶活性:蛋白酶能产生蛋白质吗?
  • 批准号:
    RGPIN-2019-06720
  • 财政年份:
    2019
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual
Side effect-free cathepsin K targeting drugs for skeletal diseases
用于骨骼疾病的无副作用组织蛋白酶 K 靶向药物
  • 批准号:
    523434-2018
  • 财政年份:
    2018
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Collaborative Health Research Projects
Exosites, ligands and complex formation: novel determinants of protease specificity
外位点、配体和复合物形成:蛋白酶特异性的新决定因素
  • 批准号:
    326803-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual
Exosites, ligands and complex formation: novel determinants of protease specificity
外位点、配体和复合物形成:蛋白酶特异性的新决定因素
  • 批准号:
    326803-2013
  • 财政年份:
    2015
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual
Exosites, ligands and complex formation: novel determinants of protease specificity
外位点、配体和复合物形成:蛋白酶特异性的新决定因素
  • 批准号:
    326803-2013
  • 财政年份:
    2014
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual
Exosites, ligands and complex formation: novel determinants of protease specificity
外位点、配体和复合物形成:蛋白酶特异性的新决定因素
  • 批准号:
    326803-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 2.19万
  • 项目类别:
    Discovery Grants Program - Individual

相似国自然基金

新型二茂铁基四咪唑类大环配体的合成、表征及其金属配合物在非均相C-C偶联反应中的应用研究
  • 批准号:
    21102132
  • 批准年份:
    2011
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
  • 批准号:
    10752555
  • 财政年份:
    2024
  • 资助金额:
    $ 2.19万
  • 项目类别:
Role of Frizzled 5 in NK cell development and antiviral host immunity
Frizzled 5 在 NK 细胞发育和抗病毒宿主免疫中的作用
  • 批准号:
    10748776
  • 财政年份:
    2024
  • 资助金额:
    $ 2.19万
  • 项目类别:
REGULATION OF BONE MARROW MESENCHYMAL STEM CELLS BY VCAM1
VCAM1 对骨髓间充质干细胞的调节
  • 批准号:
    10537391
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
Bioorthogonal probe development for highly parallel in vivo imaging
用于高度并行体内成像的生物正交探针开发
  • 批准号:
    10596786
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
EGF Receptor Endocytosis: Mechanisms and Role in Signaling
EGF 受体内吞作用:机制及其在信号传导中的作用
  • 批准号:
    10552100
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
Decoding the functional pleiotropy of IL-20Rβ ligands in inflammation and tumorigenesis
解码 IL-20Rβ 配体在炎症和肿瘤发生中的功能多效性
  • 批准号:
    10350447
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
An Engineered Hydrogel Platform to Improve Neural Organoid Reproducibility for a Multi-Organoid Disease Model of 22q11.2 Deletion Syndrome
一种工程水凝胶平台,可提高 22q11.2 缺失综合征多器官疾病模型的神经类器官再现性
  • 批准号:
    10679749
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
Novel approach to identify RNA-bound small molecules in vivo
体内鉴定 RNA 结合小分子的新方法
  • 批准号:
    10646626
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
Mechanistic dissection of allosteric modulation and nonproteolytic chaperone activity of human insulin-degrading enzyme
人胰岛素降解酶变构调节和非蛋白水解伴侣活性的机制剖析
  • 批准号:
    10667987
  • 财政年份:
    2023
  • 资助金额:
    $ 2.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了